178 related articles for article (PubMed ID: 21941148)
1. Complete resolution of sickle cell chronic pain with high dose vitamin D therapy: a case report and review of the literature.
Osunkwo I
J Pediatr Hematol Oncol; 2011 Oct; 33(7):549-51. PubMed ID: 21941148
[TBL] [Abstract][Full Text] [Related]
2. Apropos "complete resolution of sickle cell chronic pain with high-dose vitamin D therapy: a case report and review of the literature".
Arya SC; Agarwal N
J Pediatr Hematol Oncol; 2012 May; 34(4):e172-3. PubMed ID: 22430588
[No Abstract] [Full Text] [Related]
3. Severe vitamin D deficiency in a patient with sickle cell disease: a case study with literature review.
Kaza PL; Moulton T
J Pediatr Hematol Oncol; 2014 May; 36(4):293-6. PubMed ID: 24276034
[TBL] [Abstract][Full Text] [Related]
4. Osteomalacia as a result of vitamin D deficiency.
Bhan A; Rao AD; Rao DS
Endocrinol Metab Clin North Am; 2010 Jun; 39(2):321-31, table of contents. PubMed ID: 20511054
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for vitamin D deficiency in sickle cell disease.
Han J; Zhang X; Saraf SL; Gowhari M; Molokie RE; Hassan J; Jain S; Shah BN; Abbasi T; Machado RF; Gordeuk VR
Br J Haematol; 2018 Jun; 181(6):828-835. PubMed ID: 29767851
[TBL] [Abstract][Full Text] [Related]
6. Response to Long-term Vitamin D Therapy for Bone Disease in Children With Sickle Cell Disease.
Williams KM; Lee MT; Licursi M; Brittenham GM; Fennoy I
J Pediatr Hematol Oncol; 2018 Aug; 40(6):458-461. PubMed ID: 29668535
[TBL] [Abstract][Full Text] [Related]
7. The 2011 IOM report on vitamin D and calcium requirements for north america: clinical implications for providers treating patients with low bone mineral density.
Rosen CJ; Gallagher JC
J Clin Densitom; 2011; 14(2):79-84. PubMed ID: 21787514
[TBL] [Abstract][Full Text] [Related]
8. An update on the recent literature on sickle cell bone disease.
Osunkwo I
Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):539-46. PubMed ID: 24150191
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D supplementation and pain-related emergency department visits in children with sickle cell disease.
Hood AM; Quinn CT; King CD; Shook LM; Peugh JL; Crosby LE
Complement Ther Med; 2020 Mar; 49():102342. PubMed ID: 32147073
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D therapy in clinical practice. One dose does not fit all.
Ryan PJ
Int J Clin Pract; 2007 Nov; 61(11):1894-9. PubMed ID: 17935548
[TBL] [Abstract][Full Text] [Related]
11. Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment.
Lanham-New SA
Proc Nutr Soc; 2008 May; 67(2):163-76. PubMed ID: 18412990
[TBL] [Abstract][Full Text] [Related]
12. [Should the vitamin D level be determined for all fracture patients?].
van den Bergh J; van Geel T; Geusens P
Ned Tijdschr Geneeskd; 2010; 154():A1758. PubMed ID: 20482906
[TBL] [Abstract][Full Text] [Related]
13. [Effect of vitamin D on muscle strength and relevance in regard to osteoporosis prevention].
Bischoff-Ferrari HA; Conzelmann M; Dick W; Theiler R; Stähelin HB
Z Rheumatol; 2003 Dec; 62(6):518-21. PubMed ID: 14685712
[TBL] [Abstract][Full Text] [Related]
14. Reducing fracture risk with calcium and vitamin D.
Lips P; Bouillon R; van Schoor NM; Vanderschueren D; Verschueren S; Kuchuk N; Milisen K; Boonen S
Clin Endocrinol (Oxf); 2010 Sep; 73(3):277-85. PubMed ID: 20796001
[TBL] [Abstract][Full Text] [Related]
15. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
Jones G; Hogan DB; Yendt E; Hanley DA
CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
[TBL] [Abstract][Full Text] [Related]
16. Osteopenia and vitamin D deficiency in children with sickle cell disease.
Chapelon E; Garabedian M; Brousse V; Souberbielle JC; Bresson JL; de Montalembert M
Eur J Haematol; 2009 Dec; 83(6):572-8. PubMed ID: 19682065
[TBL] [Abstract][Full Text] [Related]
17. [Severe vitamin D deficiency and hypocalcaemia after bariatric surgery].
Korpershoek HW; Witteman EM; Meinardi JR; Vollaard EJ
Ned Tijdschr Geneeskd; 2010; 154():A827. PubMed ID: 20132568
[TBL] [Abstract][Full Text] [Related]
18. Is there a role for therapeutic drug monitoring of vitamin D level as a surrogate marker for fracture risk?
Isenor JE; Ensom MH
Pharmacotherapy; 2010 Mar; 30(3):254-64. PubMed ID: 20180609
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D replacement for cirrhosis-related bone disease.
Crawford BA; Labio ED; Strasser SI; McCaughan GW
Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):689-99. PubMed ID: 17130879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
